SCHEMBL19862807

SCHEMBL19862807

CC(C)(C)c1cc(-c2ccccc2)nc(-c2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.46
KMT2A Q03164 10/20 0.46
RAB9A P51151 2/20 0.46
MAPT P10636 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 2/20 0.46
TSHR P16473 1/20 0.46
ATM Q13315 1/20 0.46
ADORA1 P30542 3/20 0.45
ADORA2A P29274 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CTRC Q99895 1/20 0.45
NTSR1 P30989 1/20 0.44
KIF11 P52732 1/20 0.43
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102460 0.96 MEN1 (0.50) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL25491383 0.91 MEN1 (0.59) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL18326863 0.90 CYP19A1 (0.46) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL23959669 0.89 MEN1 (0.49) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL19735240 0.89 MEN1 (0.51) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL19862793 0.89 MEN1 (0.51) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL24795565 0.88 CYP1A1 (0.58) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL25516950 0.86 ASIC3 (0.46) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL13203368 0.85 MEN1 (0.49) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL23959657 0.85 RXRA (0.47) MEN1KMT2ARAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885RAB9A 3245/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885RAB9A 3245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.